Cargando…
Thymus and activation‐regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study
Classical Hodgkin lymphoma (cHL) is characterised by malignant Hodgkin Reed–Sternberg cells located in an inflammatory microenvironment. Blood biomarkers result from active cross‐talk between malignant and non‐malignant cells. One promising biomarker in adult patients with cHL is thymus and activati...
Autores principales: | Zijtregtop, Eline A. M., Diez, Claudius, Zwaan, C. Michel, Veening, Margreet A., Beishuizen, Auke, Meyer‐Wentrup, Friederike A. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087307/ https://www.ncbi.nlm.nih.gov/pubmed/36128637 http://dx.doi.org/10.1111/bjh.18473 |
Ejemplares similares
-
Plasma thymus and activation‐regulated chemokine (TARC) as diagnostic marker in pediatric Hodgkin lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2020) -
Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2021) -
The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022) -
Nivolumab plus Brentuximab vedotin +/- bendamustine combination therapy: a safe and effective treatment in pediatric recurrent and refractory classical Hodgkin lymphoma
por: Greve, Patrick, et al.
Publicado: (2023) -
Machine Learning Logistic Regression Model for Early Decision Making in Referral of Children with Cervical Lymphadenopathy Suspected of Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2023)